FI60319C - Foerfarande foer paovisning eller bestaemning av antikroppar i kroppsvaetskor med hjaelp av kaenda antigener eller foer bestaemning av antigener med hjaelp av kaenda antikroppar fraon kroppsvaetskor samt medel foer utfoerande av foerfarandet - Google Patents
Foerfarande foer paovisning eller bestaemning av antikroppar i kroppsvaetskor med hjaelp av kaenda antigener eller foer bestaemning av antigener med hjaelp av kaenda antikroppar fraon kroppsvaetskor samt medel foer utfoerande av foerfarandet Download PDFInfo
- Publication number
- FI60319C FI60319C FI761640A FI761640A FI60319C FI 60319 C FI60319 C FI 60319C FI 761640 A FI761640 A FI 761640A FI 761640 A FI761640 A FI 761640A FI 60319 C FI60319 C FI 60319C
- Authority
- FI
- Finland
- Prior art keywords
- med
- kroppsvaetskor
- kaenda
- antigener
- antikroppar
- Prior art date
Links
- 101100148710 Clarkia breweri SAMT gene Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 claims description 30
- 102000036639 antigens Human genes 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 28
- 210000001124 body fluid Anatomy 0.000 claims description 19
- 239000010839 body fluid Substances 0.000 claims description 19
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims description 14
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims description 14
- 239000003463 adsorbent Substances 0.000 claims description 10
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
- 229940024545 aluminum hydroxide Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 description 20
- 239000013566 allergen Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000872 buffer Substances 0.000 description 13
- 239000000284 extract Substances 0.000 description 12
- 241000283073 Equus caballus Species 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 208000001840 Dandruff Diseases 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229940074608 allergen extract Drugs 0.000 description 6
- 229960004784 allergens Drugs 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- -1 halogen cyanide Chemical class 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000746983 Phleum pratense Species 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 206010001742 Allergy to animal Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK259875 | 1975-06-10 | ||
| DK259875AA DK140815B (da) | 1975-06-10 | 1975-06-10 | Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI761640A7 FI761640A7 (cs) | 1976-12-11 |
| FI60319B FI60319B (fi) | 1981-08-31 |
| FI60319C true FI60319C (fi) | 1981-12-10 |
Family
ID=8113555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI761640A FI60319C (fi) | 1975-06-10 | 1976-06-09 | Foerfarande foer paovisning eller bestaemning av antikroppar i kroppsvaetskor med hjaelp av kaenda antigener eller foer bestaemning av antigener med hjaelp av kaenda antikroppar fraon kroppsvaetskor samt medel foer utfoerande av foerfarandet |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4127385A (cs) |
| JP (1) | JPS51151323A (cs) |
| AU (1) | AU505801B2 (cs) |
| BE (1) | BE842821A (cs) |
| CA (1) | CA1073352A (cs) |
| CH (1) | CH625345A5 (cs) |
| DE (1) | DE2624814C2 (cs) |
| DK (1) | DK140815B (cs) |
| FI (1) | FI60319C (cs) |
| FR (1) | FR2314499A1 (cs) |
| GB (1) | GB1503409A (cs) |
| LU (1) | LU75124A1 (cs) |
| NL (1) | NL7606248A (cs) |
| NO (1) | NO147048C (cs) |
| SE (1) | SE427218B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1549069A (en) * | 1976-12-10 | 1979-08-01 | Erba Farmitalia | Enzyme linked immunoassay |
| JPS5917388B2 (ja) * | 1979-02-22 | 1984-04-20 | 富士レビオ株式会社 | 間接凝集反応用吸収剤 |
| JPS56143955A (en) * | 1980-04-10 | 1981-11-10 | Fujirebio Inc | Method for diagnosis of initial infection of syphilis |
| EP0084531B1 (en) * | 1981-07-31 | 1987-05-20 | Mount Sinai School Of Medicine Of The City University Of New York | Assay for viruses |
| US4551431A (en) * | 1983-04-21 | 1985-11-05 | Phillips Petroleum Company | The use of gallium and indium salts for the immobilization of proteins |
| WO1991002980A1 (en) * | 1989-08-24 | 1991-03-07 | Ramsey Foundation | Method and apparatus for the measurement of organic antigens |
| FR2832507B1 (fr) * | 2001-11-20 | 2004-02-20 | Stago Diagnostica | Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales |
| CA2532726C (en) * | 2003-08-05 | 2013-03-12 | Alk Abello A/S | Evaluation of adjuvanted vaccines |
| US7867715B2 (en) * | 2003-08-05 | 2011-01-11 | Alk-Abello A/S | Method of evaluating the immunological activity of a vaccine |
| GB0607462D0 (en) * | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
| EP2344188B1 (en) * | 2008-10-02 | 2017-02-15 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
| US20100183675A1 (en) * | 2009-01-22 | 2010-07-22 | Allan Watkinson | Stable vaccine compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604135A (cs) * | 1967-09-26 | 1971-07-12 | ||
| JPS4849919A (cs) * | 1971-10-23 | 1973-07-14 | ||
| US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| US3776698A (en) * | 1972-01-24 | 1973-12-04 | Nuclear Med Lab | Test for thyroid hormone |
| NL7316346A (cs) * | 1972-12-11 | 1974-06-13 |
-
1975
- 1975-06-10 DK DK259875AA patent/DK140815B/da not_active IP Right Cessation
-
1976
- 1976-05-27 US US05/690,445 patent/US4127385A/en not_active Expired - Lifetime
- 1976-05-28 SE SE7606082A patent/SE427218B/xx not_active IP Right Cessation
- 1976-06-01 CH CH684276A patent/CH625345A5/de not_active IP Right Cessation
- 1976-06-02 DE DE2624814A patent/DE2624814C2/de not_active Expired
- 1976-06-04 FR FR7617016A patent/FR2314499A1/fr active Granted
- 1976-06-04 GB GB23206/76A patent/GB1503409A/en not_active Expired
- 1976-06-07 CA CA254,269A patent/CA1073352A/en not_active Expired
- 1976-06-09 AU AU14753/76A patent/AU505801B2/en not_active Expired
- 1976-06-09 LU LU75124A patent/LU75124A1/xx unknown
- 1976-06-09 FI FI761640A patent/FI60319C/fi not_active IP Right Cessation
- 1976-06-09 NL NL7606248A patent/NL7606248A/xx not_active Application Discontinuation
- 1976-06-09 NO NO761962A patent/NO147048C/no unknown
- 1976-06-10 BE BE167819A patent/BE842821A/xx not_active IP Right Cessation
- 1976-06-10 JP JP51068175A patent/JPS51151323A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI761640A7 (cs) | 1976-12-11 |
| FI60319B (fi) | 1981-08-31 |
| DK140815C (cs) | 1980-04-08 |
| GB1503409A (en) | 1978-03-08 |
| CA1073352A (en) | 1980-03-11 |
| BE842821A (fr) | 1976-10-01 |
| US4127385A (en) | 1978-11-28 |
| CH625345A5 (cs) | 1981-09-15 |
| SE427218B (sv) | 1983-03-14 |
| LU75124A1 (cs) | 1977-01-24 |
| FR2314499A1 (fr) | 1977-01-07 |
| NO761962L (cs) | 1976-12-13 |
| NL7606248A (nl) | 1976-12-14 |
| AU505801B2 (en) | 1979-12-06 |
| AU1475376A (en) | 1977-12-15 |
| JPS51151323A (en) | 1976-12-25 |
| DE2624814C2 (de) | 1985-02-21 |
| DE2624814A1 (de) | 1976-12-23 |
| FR2314499B1 (cs) | 1982-08-13 |
| DK259875A (cs) | 1976-12-11 |
| SE7606082L (sv) | 1976-12-11 |
| NO147048C (no) | 1983-01-19 |
| NO147048B (no) | 1982-10-11 |
| DK140815B (da) | 1979-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI60319C (fi) | Foerfarande foer paovisning eller bestaemning av antikroppar i kroppsvaetskor med hjaelp av kaenda antigener eller foer bestaemning av antigener med hjaelp av kaenda antikroppar fraon kroppsvaetskor samt medel foer utfoerande av foerfarandet | |
| EP0005271A2 (en) | Method and kit for enzyme immunoassay of biological substances | |
| KR100209072B1 (ko) | 숙신이미드함유 중합체로 생물학적 활성 시약을 제조하는 방법, 분석 요소 및 이것의 사용방법 | |
| US3995019A (en) | Diagnostic reagent system | |
| JPH01202663A (ja) | 固定化したビオチン化受容体を用いるリガンド測定のための試験装置，キットおよび方法 | |
| EP2100122A2 (en) | Poly (ethylene glycol) anti-body detection assays and kits for performing thereof | |
| US4548909A (en) | Method of diagnosis | |
| JPS6161062B2 (cs) | ||
| CN118068016A (zh) | 用于猫三联抗体检测的胶体金层析试剂条、检测试剂笔及其应用 | |
| JPH04213059A (ja) | 抗体の検出のための棒状プローブ装置 | |
| JPH0421637A (ja) | キチン誘導体又はキトサンを表面に修飾した高分子微粒子並びにその製造方法 | |
| CN109633163B (zh) | 降钙素原/c反应蛋白二合一检测试剂盒 | |
| CN106896094A (zh) | 一种同时检测cle、rac和sbl的方法及其专用纸芯片 | |
| Margel | Affinity separation with polyaldehyde microsphere beads | |
| Sarsfield et al. | A modified radioallergosorbent test for the in vitro detection of allergen antibodies | |
| McArthur et al. | A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945. | |
| AU625344B2 (en) | Chlamydia half-sandwich immunoassay | |
| CN117825692A (zh) | 一种荧光微球冻干保护剂及其冻干制剂与用途 | |
| JPS60222774A (ja) | 活性化固相体およびその活性化方法ならびに免疫反応性固相体およびその製造方法と検定方法 | |
| Hirata et al. | The use of a specific antibody adsorbent for estimation of total antibody against bovine serum albumin | |
| Suzuki et al. | Anisakiasis: preparation of a stable antigen for indirect fluorescent antibody test | |
| US4783525A (en) | Preparation of reagent for immune complex isolation | |
| US4403040A (en) | Diagnostic test for the detection of a specific tumor antigen with CoA-SPC | |
| JP3938627B2 (ja) | リジン親和性物質の測定方法 | |
| JPS58221166A (ja) | 免疫化学的測定用担体および該担体を使用した測定試薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: WEEKE, BENT |